Search results
Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem
New York Times· 1 day agoThe company has told countries that it can supply only 18.8 million of the 29.6 million doses it was...
Pet Beaver Takes His First Dip In the Family Pool and It’s Just Too Cute
PetHelpful via AOL· 1 day agoIf you need a dose of adorableness to brighten up your day, look no further than this video that...
Ocugen Announces Dosing Completion of Subjects with Geographic Atrophy in Cohort 2 of Phase 1/2...
Morningstar· 10 hours agoGA affects approximately 1 million people in the United States alone.
WHO's top scientist sounds alarm about bird flu and need for vaccine development
USA Today· 2 hours agoWorld Health Organization’s top scientist said this week the recent bird flu outbreak is of “great...
...Announces Product Donations To Direct Relief of More Than 7 Million Doses of Medicine To Support...
Morningstar· 5 hours agoSTEINHAUSEN, SWITZERLAND / ACCESSWIRE / April 19, 2024 / Viatris Inc. (NASDAQ:VTRS), a global healthcare company, today announced that it has donated more than 7 million doses ...
Fact check: Biden makes false and misleading claims during Pennsylvania campaign swing
CNN via AOL· 1 hour agoChina reported having more than 740 million employed people at the end of 2023, while it also...
ETH restaking drives DeFi TVL to $100B, Solana releases patch for network congestion: Finance...
The Cointelegraph· 1 hour agoWelcome to Finance Redefined, your weekly dose of essential decentralized finance (DeFi) insights — a newsletter crafted to bring you the most significant developments from ...
Even more doses of Eli Lilly's Zepbound and Mounjaro are officially in a shortage, FDA says
Quartz· 2 days agoThe U.S. Food and Drug Administration updated its drug shortage database on Wednesday to include...
Weight-loss drug suffers supply shortage
Newsweek· 1 day agoMost doses of Zepbound, the latest weight-loss drug to hit the market, is in short supply due to increased demand, according to the U.S. Food and Drug...
bluebird (BLUE) Underperforms Industry YTD Amid Challenges
Zacks via Yahoo Finance· 3 days agoAlso, BLUE has priced Lyfgenia at $3.1 million per dose. Vertex and CRISPR's gene therapy will cost...